Catalyst Wire Dossier Catalyst Wire Dossier

Mocravimod

Mocravimod · Priothera SAS
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Mocravimod, covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT [Phase 3]

See pricing